HYDROGENE THERAPEUTICS INC

Biotech · Private

Non-viral gene delivery system for liver-directed gene therapy in hereditary tyrosinemia type 1

Grants
$294K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
15
0 granted · 15 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Lifelong Correction of Hereditary Tyrosinemia Type 1 and Other Monogenic Liver Diseases using Liver-specific Hydrodynamic Gene Delivery through the Biliary System$293,987
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2733IMAGEN BIOWORKS INC.——
2734TRAVERSE BIOTECH II INC——
2735INCOMPUTABLE LLC——
2736HYDROGENE THERAPEUTICS INC——
2737LUNA BIOSCIENCE, INC.——
2738DFH Pharma, Inc——
2739MIXEDLCMEDIA LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 15
  • Compositions And Methods For Treating Wilson's Diseaseapplication
  • A Catheter For Hydrodynamic Injectionapplication
  • Methods And Compositions For Hydrodynamic Gene Deliveryapplication
  • Compositions And Methods For Treating Wilson's Diseaseapplication
  • Compositions And Methods For Biliary Hydrodynamic Injection Into The Liverapplication
  • Pressure-guided Hydrodynamic Injectionapplication
  • Hydrodynamic Gene Delivery Into Tumorsapplication
  • Gene Delivery Methods Into Primate Liverapplication
  • Compositions And Methods For Hydrodynamic Gene Delivery Into The Pancreasapplication
  • A Catheter For Hydrodynamic Injectionapplication
  • Compositions And Methods For Hydrodynamic Gene Delivery Into The Kidneyapplication
  • Methods Of Injection Through The Common Bile Ductapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.